JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265647

Human LMF2 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

LMF2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and 50 bp deletion in exon 2.

View Alternative Names

LMF2_HUMAN, Lipase maturation factor 2, OTTHUMP00000196605, TMEM112B, TMEM153, Transmembrane protein 112B, Transmembrane protein 153

2 Images
Sanger Sequencing - Human LMF2 knockout HeLa cell line (AB265647)
  • Sanger seq

Unknown

Sanger Sequencing - Human LMF2 knockout HeLa cell line (AB265647)

Allele-2 : 1 bp deletion in exon 2.

Sanger Sequencing - Human LMF2 knockout HeLa cell line (AB265647)
  • Sanger seq

Unknown

Sanger Sequencing - Human LMF2 knockout HeLa cell line (AB265647)

Allele-1 : 50 bp deletion in exon 2.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and 50 bp deletion in exon 2

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265647-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265647 Human LMF2 knockout HeLa cell line", "number":"AB265647-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265647-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265647 Human LMF2 knockout HeLa cell line", "number":"AB265647-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
LMF2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein LMF2 also known as Lipase Maturation Factor 2 plays an important role in the maturation of certain lipases. It is a small protein with a molecular mass of approximately 22 kDa. LMF2 is expressed in various tissues but shows a higher expression level in the liver and adipose tissue. It is important for the post-translational modification of lipases which are critical enzymes for lipid metabolism.
Biological function summary

LMF2 assists in the proper folding and maturation of lipases ensuring they function correctly. It acts as part of a larger maturation complex which also includes its homolog LMF1. This complex facilitates the activation of lipases that require processing before functioning properly. Mature lipases participate in breaking down lipid molecules releasing fats and other important metabolites necessary for cellular energy and storage.

Pathways

LMF2 integrates into the lipid metabolism and energy homeostasis pathways. It notably interacts with enzymes such as lipoprotein lipase which plays a critical role in hydrolyzing triglycerides in lipoproteins into free fatty acids. LMF2's function also links it to hepatic lipase activity further embedding it in the pathways that control the distribution and management of lipids across different bodily tissues.

LMF2 could potentially relate to metabolic conditions such as hyperlipidemia or obesity due to its involvement in lipid metabolism. The dysfunction or misregulation of LMF2 might disrupt normal lipid metabolism leading to abnormal accumulation of fats in the body. Moreover through its relationship with lipases such as lipoprotein lipase disruptions in LMF2's function might contribute to cardiovascular disorders given the importance of lipid processing in maintaining cardiovascular health.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com